BioinformaticsBioinformaticsPeer-reviewed journal article
Sensitive and specific post-call filtering of genetic variants in xenograft and primary tumors
Brian K. MannakeeiD, Uthra Balaji, Agnieszka Katarzyna WitkiewicziD, Ryan N. GutenkunstiD, Erik S. KnudseniD
Abstract
MotivationTumor genome sequencing offers great promise for guiding research and therapy, but spurious variant calls can arise from multiple sources. Mouse contamination can generate many spurious calls when sequencing patient-derived xenografts (PDXs). Paralogous genome sequences can also generate spurious calls when sequencing any tumor. We developed a BLAST-based algorithm, MAPEX, to identify and filter out spurious calls from both these sources.\n\nResultsWhen calling variants from xenografts, MAPEX has similar sensitivity and specificity to more complex algorithms. When applied to any tumor, MAPEX also automatically flags calls that potentially arise from paralogous sequences. Our implementation, mapexr, runs quickly and easily on a desktocomputer. MAPEX is thus a useful addition to almost any pipeline for calling genetic variants in tumors.
- organism: mouse
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 6
- FWCI
- 0.08
- Field percentile
- 37th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- pdxBlacklist: Identifying artefactual variants in patient-derived xenograft samples
Max Salm, Sven-Eric Schelhorn, … Thomas Grombacher·bioRxiv·Aug 25, 2017
- Sample-Index Misassignment Impacts Tumor Exome Sequencing
Daniel Vodák, Susanne Lorenz, … Eivind J. Hovig·Scientific ReportsPeer-reviewed·Mar 28, 2018
- SMAP: exploiting high-throughput sequencing data of patient derived xenografts
Yuna Blum, Aurélien de Reyniès, … Rémy Nicolle·bioRxiv·Oct 11, 2018
- The Impact of Variant Calling on Substitution Mutational Signature Inference
Zichen Jiang, Jessica N. Au, … Ludmil B. Alexandrov·bioRxiv·Dec 12, 2025
- Evaluating the analytical validity of mutation calling pipeline for tumor whole exome sequencing
Chinyi Cheng, Jia‐Hsin Huang, Jacob Shujui Hsu·bioRxiv·Nov 17, 2022
- Synth4bench: Synthetic Data Generation for Benchmarking Tumor-Only Somatic Variant Calling Algorithms
Styliani-Christina Fragkouli, Nikos Pechlivanis, … F. Psomopoulos·Frontiers in BioinformaticsPeer-reviewed·Jul 16, 2026